Virapur

Virapur is a specialized contract research organization (CRO) that provides virology-focused services to the biopharmaceutical industry. The company offers a comprehensive suite of services including virus production, purification, and characterization, as well as viral clearance studies and assay development. Virapur supports clients in the development of vaccines, oncolytic viruses, and viral vectors for gene therapy, such as AAV and lentivirus. Based in San Diego, California, the company has established a reputation for technical expertise in handling a diverse range of viral agents. In January 2021, Virapur was acquired by Charles River Laboratories to enhance its end-to-end cell and gene therapy solution portfolio.